单位剂量包装市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球单位剂量包装市场价值为 296 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 8.9%。这一强劲成长是由各行各业对精确、便捷的剂量解决方案日益增长的需求推动的，尤其是药品、营养保健品和膳食补充剂。单位剂量包装因其能够增强患者依从性、减少用药错误并提高安全性而受到关注。随着世界各地的医疗保健系统强调准确剂量的重要性，製药公司越来越多地采用泡罩包装、预填充注射器、安瓿瓶和小瓶等单位剂量形式，以确保安全有效地输送药物。此外，个人化营养和预防性医疗保健的日益普及扩大了单位剂量包装在功能性食品和益生菌补充剂中的使用，为市场创造了新的成长机会。

市场的成长轨迹也受到监管政策的影响，这些政策提倡使用更安全和防篡改的包装，特别是在製药领域。随着人们越来越关注减少用药错误和提高病人安全，单位剂量包装形式正成为首选。此外，尤其是在后疫情时代，对便利性包装解决方案的需求激增，进一步推动了市场的发展。消费者现在寻求的是一次性、卫生、便携的包装形式，以适应他们的忙碌生活方式。这一趋势也延伸到了食品和饮料行业，单剂量小袋和小包装因其易于使用和精确的份量控製而越来越受欢迎。因此，製造商正在大力投资先进的包装技术和永续材料，以满足不断变化的消费者偏好，同时遵守严格的监管要求。

市场按材料类型细分，主要类别为塑胶、铝、纸和纸板以及玻璃。 2024 年，塑胶将占据 53% 的市场份额，这得益于其强度、多功能性以及提供有效屏障保护的能力。塑胶包装在确保安全的同时延长了产品的保质期，成为药品和食品包装的首选。然而，对环境永续性的日益重视促使製造商开发环保替代品，例如可回收和可生物降解的塑胶。这些创新提供了环保解决方案，同时又不损害包装功能，使塑胶领域继续占据市场主导地位。

就包装类型而言，市场分为泡罩包装、小袋和小袋、安瓿瓶和小瓶、预充式註射器等。 2024 年泡罩包装占 42.1% 的份额，反映了其在药品和营养保健品领域的广泛应用。製造商正在透过可剥离的盖子、易于打开的设计和改进的阻隔性能来增强泡罩包装，以确保产品安全，同时提供用户友好的体验。这些创新符合对平衡功能性和永续性的包装解决方案日益增长的需求，推动了泡罩包装在市场上的普及。

受先进包装解决方案需求旺盛的推动，北美单位剂量包装市场到 2024 年将占全球份额的 34.8%。该地区专注于提高患者安全和药物依从性，导致预充式註射器、单剂量小瓶和条状包装等单位剂量形式的采用激增。糖尿病、心血管疾病和呼吸系统疾病等慢性病的盛行率不断上升，进一步促使製药公司投资包装技术，以最大限度地减少用药错误并改善治疗效果。因此，北美仍然是单位剂量包装创新的关键市场，持续的研发投资预计将塑造该产业的未来。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 精准计量解决方案的需求不断增长
    • 製药业的成长
    • 非处方药（OTC）的成长
    • 营养保健品和补充剂中单位剂量包装的使用日益增多
    • 扩大即时检测与诊断试剂盒
  • 产业陷阱与挑战
    • 先进包装机械初期投资高
    • 一次性塑胶垃圾的环境问题
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：依材料类型，2021-2034

• 主要趋势
• 塑胶
• 铝
• 纸和纸板
• 玻璃

第六章：市场估计与预测：依包装类型，2021-2034

• 主要趋势
• 泡罩包装
• 小袋和小袋
• 安瓿瓶与小瓶
• 预充式註射器
• 其他的

第七章：市场估计与预测：按应用，2021-2034

• 主要趋势
• 口服药物
• 注射剂
• 外用和透皮
• 其他的

第八章：市场估计与预测：依最终用途，2021-2034

• 主要趋势
• 製药
• 化妆品和个人护理
• 营养保健品
• 其他的

第九章：市场估计与预测：按地区，2021-2034

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第十章：公司简介

• Adelphi Healthcare Packaging
• Amcor
• AptarGroup
• Berry Global
• Borosil
• Catalent
• Constantia Flexibles
• Corning
• DWK Life Sciences
• Gerresheimer
• Glenroy
• Lameplast
• Nipro
• Schott
• SGD Pharma
• Shiotani Glass
• Stevanato Group
• Unit Pack Company
• Valmatic
• West Pharmaceutical Services

The Global Unit Dose Packaging Market was valued at USD 29.6 billion in 2024 and is projected to grow at a CAGR of 8.9% between 2025 and 2034. This robust growth is fueled by the rising demand for precise and convenient dosing solutions across industries, particularly pharmaceuticals, nutraceuticals, and dietary supplements. Unit dose packaging has gained traction due to its ability to enhance patient compliance, reduce medication errors, and improve safety. As healthcare systems worldwide emphasize the importance of accurate dosing, pharmaceutical companies are increasingly adopting unit dose formats such as blister packs, pre-filled syringes, ampoules, and vials to ensure safe and effective medication delivery. Furthermore, the growing popularity of personalized nutrition and preventive healthcare has expanded the use of unit dose packaging in functional foods and probiotic supplements, creating new growth opportunities in the market.

The market's growth trajectory is also influenced by regulatory policies that promote the use of safer and tamper-evident packaging, particularly in the pharmaceutical sector. With an increasing focus on minimizing medication errors and enhancing patient safety, unit dose packaging formats are becoming a preferred choice. Additionally, the surge in demand for convenience-driven packaging solutions, especially in the post-COVID-19 era, has further propelled the market. Consumers now seek single-use, hygienic, and portable packaging formats that align with their on-the-go lifestyles. The trend has also extended to the food and beverage industry, where single-dose sachets and pouches are gaining momentum due to their ease of use and precise portion control. As a result, manufacturers are investing heavily in advanced packaging technologies and sustainable materials to cater to evolving consumer preferences while complying with stringent regulatory requirements.

The market is segmented by material type, with plastic, aluminum, paper & paperboard, and glass being the primary categories. In 2024, the plastic segment accounted for 53% of the market share, driven by its strength, versatility, and ability to provide effective barrier protection. Plastic packaging extends product shelf life while ensuring safety, making it a preferred choice in pharmaceuticals and food packaging. However, the increasing emphasis on environmental sustainability has prompted manufacturers to develop eco-friendly alternatives, such as recyclable and biodegradable plastics. These innovations provide environmentally conscious solutions without compromising packaging functionality, positioning the plastic segment for continued dominance in the market.

In terms of packaging types, the market is divided into blister packs, sachets & pouches, ampoules & vials, pre-filled syringes, and others. Blister packs held a 42.1% share in 2024, reflecting their widespread use in pharmaceutical and nutraceutical applications. Manufacturers are enhancing blister packs with peelable lids, easy-open designs, and improved barrier properties to ensure product safety while delivering a user-friendly experience. These innovations align with the growing demand for packaging solutions that balance functionality and sustainability, driving the popularity of blister packs in the market.

North America unit dose packaging market accounted for 34.8% of the global share in 2024, propelled by a high demand for advanced packaging solutions. The region's focus on improving patient safety and medication adherence has led to a surge in the adoption of unit dose formats such as pre-filled syringes, single-dose vials, and stick packs. The increasing prevalence of chronic conditions, including diabetes, cardiovascular diseases, and respiratory issues, has further driven pharmaceutical companies to invest in packaging technologies that minimize medication errors and improve treatment outcomes. As a result, North America remains a critical market for unit dose packaging innovations, with continued investments in research and development expected to shape the future of the industry.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for precision dosing solutions
    • 3.2.1.2 Growth in the pharmaceutical industry
    • 3.2.1.3 Growth in over-the-counter (OTC) medicines
    • 3.2.1.4 Increasing use of unit dose packaging in nutraceuticals and supplements
    • 3.2.1.5 Expansion of point-of-care testing and diagnostic kits
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High initial investment in advanced packaging machinery
    • 3.2.2.2 Environmental concerns regarding single-use plastic waste
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates & Forecast, By Material Type, 2021-2034 (USD Billion & Kilo Tons)

• 5.1 Key trends
• 5.2 Plastic
• 5.3 Aluminum
• 5.4 Paper & paperboard
• 5.5 Glass

Chapter 6 Market Estimates & Forecast, By Packaging Type, 2021-2034 (USD Billion & Kilo Tons)

• 6.1 Key trends
• 6.2 Blister packs
• 6.3 Sachets & pouches
• 6.4 Ampoules & vials
• 6.5 Pre-filled syringes
• 6.6 Others

Chapter 7 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion & Kilo Tons)

• 7.1 Key trends
• 7.2 Oral drugs
• 7.3 Injectables
• 7.4 Topical & transdermal
• 7.5 Others

Chapter 8 Market Estimates & Forecast, By End Use, 2021-2034 (USD Billion & Kilo Tons)

• 8.1 Key trends
• 8.2 Pharmaceutical
• 8.3 Cosmetics & personal care
• 8.4 Nutraceuticals
• 8.5 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Billion & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Adelphi Healthcare Packaging
• 10.2 Amcor
• 10.3 AptarGroup
• 10.4 Berry Global
• 10.5 Borosil
• 10.6 Catalent
• 10.7 Constantia Flexibles
• 10.8 Corning
• 10.9 DWK Life Sciences
• 10.10 Gerresheimer
• 10.11 Glenroy
• 10.12 Lameplast
• 10.13 Nipro
• 10.14 Schott
• 10.15 SGD Pharma
• 10.16 Shiotani Glass
• 10.17 Stevanato Group
• 10.18 Unit Pack Company
• 10.19 Valmatic
• 10.20 West Pharmaceutical Services